Trial Details

RECRUITING
Basic Information
Clinical ID c1075
Identifier NCT05076175
Trial Title A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Colitis, Ulcerative
Interventions DRUG: Ozanimod
Participant Information
Sponsor Bristol-Myers Squibb
City Phoenix
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE2|PHASE3
Time Information
Start Date 2022-05-30
Primary Completion Date 2026-05-22
Completion Date 2031-08-14